FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is the use of 7-chlor-3-(5-dimethylaminomethyl-[1,2,4]oxadiazol-3-yl)-5-methyl-4,5-dihydro-imidazo[1,5-a][1,4]benzodiazepin-6-one or a pharmaceutically acceptable salt thereof for treating various types of insomnia (terminal one, insomnia in an individual under min. 65 years, for the relief of wakefulness after the beginning of a sleep, for the prolongation of total sleep time after the beginning of a sleep - versions), pharmaceutical compositions for the appropriate application (versions) and methods of treating the various types of insomnia (versions).
EFFECT: invention is effective in treating insomnia, maintaining the sleep, terminal insomnia, including in the aged; the compound has a short half-life, ie 3-4 hours (so it causes no residual sedative action), and improves the daily activity in the aged suffering diurnal drowsiness.
61 cl, 29 dwg, 10 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING INSOMNIA | 2002 |
|
RU2560840C2 |
| COMPOSITIONS AND METHODS FOR TREATING INSOMNIA | 2015 |
|
RU2703297C2 |
| MELATONIN AGONIST THERAPY | 2007 |
|
RU2488392C2 |
| USE OF AN INVERSE AGONIST H3R FOR TREATING SLEEP DISORDER IN SHIFT WORK | 2018 |
|
RU2768894C2 |
| USING MIRTAZAPINE FOR TREATMENT OF SLEEP DISORDER | 2001 |
|
RU2270680C2 |
| METHODS FOR TREATMENT OF DISORDERS OF CIRCADIAN SLEEP RHYTHM | 2017 |
|
RU2763493C2 |
| USE OF INVERSE AGONISTS OR ANTAGONISTS OF GHRELIN RECEPTOR FOR TREATING SLEEP DISORDERS | 2013 |
|
RU2600895C2 |
| METHODS FOR USING CYCLIC AMIDE DERIVATIVES FOR TREATING SCHIZOPHRENIA | 2011 |
|
RU2576611C2 |
| GUANFACINE-BASED PHARMACEUTICAL COMPOSITIONS, SUITABLE FOR DAILY INTRODUCTION IN FORM OF SINGLE DOSED FORM | 2006 |
|
RU2435573C2 |
| METHODS FOR TREATING AND PREVENTING FATIGUE | 2010 |
|
RU2567801C2 |
